In Fig 4A, we simulated the profile of tumor volume under treatment with various combinations of anti-PD-1, anti-CTLA-4 and Sip-T, and in Fig 4B, we added ENZ, with the same protocol as in Figs 2 and 3. The gene discussed is CTLA4; the disease is neoplasm.